Ligand Pharmaceuticals (LGND) Payables (2010 - 2026)
Ligand Pharmaceuticals (LGND) posted Payables of $9.41 million for Q2 2026, up 9.6% from $8.58 million a year earlier and up 78.7% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Ligand Pharmaceuticals' Payables came in at $3.24 million, down 38.1% from FY2024.
- Annual Payables shows a five-year compound annual growth rate of -3.1% (FY2020 to FY2025).
- In prior years, Ligand Pharmaceuticals' Payables was $5.23 million in FY2024 (+115.6%), $2.43 million in FY2023 (-54.3%), $5.31 million in FY2022 (-36.8%) and $8.4 million in FY2021 (+122.1%).
- The Q2 2026 figure stands as the highest quarterly Payables since Q2 2023.
- On a year-over-year basis, Payables increased in five of the last eight quarters, with growth averaging 89.4%.
- The strongest year-over-year quarter for Payables in the past five years was Q2 2025, with growth of 378.8%; the weakest was Q3 2023, with a decline of 84.4%.
- According to Business Quant data, Payables for the three prior quarters was $5.26 million (Q1 2026), $3.24 million (Q4 2025) and $3.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Ligand Pharmaceuticals | 6.26 Bn | 2.72 Bn | - | 9.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.41 Mn |
| Mar 31, 2026 | 5.26 Mn |
| Dec 31, 2025 | 3.24 Mn |
| Sep 30, 2025 | 3.68 Mn |
| Jun 30, 2025 | 8.58 Mn |
| Mar 31, 2025 | 5.37 Mn |
| Dec 31, 2024 | 5.23 Mn |
| Sep 30, 2024 | 4.69 Mn |
| Jun 30, 2024 | 1.79 Mn |
| Mar 31, 2024 | 1.89 Mn |
| Dec 31, 2023 | 2.43 Mn |
| Sep 30, 2023 | 2.48 Mn |
| Jun 30, 2023 | 9.58 Mn |
| Mar 31, 2023 | 6.14 Mn |
| Dec 31, 2022 | 5.31 Mn |
| Sep 30, 2022 | 15.89 Mn |
| Jun 30, 2022 | 19.15 Mn |
| Mar 31, 2022 | 6.97 Mn |
| Dec 31, 2021 | 8.40 Mn |
| Sep 30, 2021 | 7.23 Mn |
API Access
Ligand Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();